These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 29281870)

  • 41. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beyond scoring: a modern interpretation of disease progression in chronic liver disease.
    Rosselli M; MacNaughtan J; Jalan R; Pinzani M
    Gut; 2013 Sep; 62(9):1234-41. PubMed ID: 23645629
    [No Abstract]   [Full Text] [Related]  

  • 43. Hepatic fibrosis: can we treat it clinically?
    Das K; Chowdhury A
    Trop Gastroenterol; 2008; 29(2):76-83. PubMed ID: 18972766
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease.
    Castera L
    Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):291-303. PubMed ID: 21497746
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis.
    Corpechot C; Carrat F; Poujol-Robert A; Gaouar F; Wendum D; Chazouillères O; Poupon R
    Hepatology; 2012 Jul; 56(1):198-208. PubMed ID: 22271046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis.
    Sun HQ; Zhang JY; Zhang H; Zou ZS; Wang FS; Jia JH
    J Viral Hepat; 2012 Jun; 19(6):396-403. PubMed ID: 22571901
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Wisteria floribunda agglutinin-positive human Mac-2 binding protein in decompensated cirrhosis.
    Uojima H; Hidaka H; Tanaka Y; Inoue T; Onoue M; Wada N; Kubota K; Nakazawa T; Shibuya A; Fujikawa T; Nakayama T; Yamanoue H; Sung JH; Kako M; Koizumi W
    J Gastroenterol Hepatol; 2018 Nov; 33(11):1889-1896. PubMed ID: 29737582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Is liver biopsy the gold standard for assessment of liver fibrosis?].
    Hu XQ
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):568-70. PubMed ID: 23227530
    [No Abstract]   [Full Text] [Related]  

  • 49. Estimation of degree of liver cirrhosis using a fibrosis score; a multivariate analysis of clinical parameters and resected specimens.
    Shimada M; Matsumata T; Adachi E; Itasaka H; Watiyama S; Sugimachi K
    Hepatogastroenterology; 1994 Apr; 41(2):177-80. PubMed ID: 8056410
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessing liver fibrosis.
    Castera L
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):541-52. PubMed ID: 19072402
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
    Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
    J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The hepatocyte phase of Gd-EOB-DTPA-enhanced MRI in the evaluation of hepatic fibrosis and early liver cirrhosis in a rat model: an experimental study.
    Ma C; Liu A; Wang Y; Geng X; Hao L; Song Q; Sun B; Wang H; Zhao G
    Life Sci; 2014 Jul; 108(2):104-8. PubMed ID: 24881519
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis.
    Lin ZH; Xin YN; Dong QJ; Wang Q; Jiang XJ; Zhan SH; Sun Y; Xuan SY
    Hepatology; 2011 Mar; 53(3):726-36. PubMed ID: 21319189
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential Roles of Angiogenesis in the Induction of Fibrogenesis and the Resolution of Fibrosis in Liver.
    Park S; Kim JW; Kim JH; Lim CW; Kim B
    Biol Pharm Bull; 2015; 38(7):980-5. PubMed ID: 26133707
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosis and epidemiology of cirrhosis.
    Lefton HB; Rosa A; Cohen M
    Med Clin North Am; 2009 Jul; 93(4):787-99, vii. PubMed ID: 19577114
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regression of Hepatic Fibrosis and Evolution of Cirrhosis: A Concise Review.
    Khan S; Saxena R
    Adv Anat Pathol; 2021 Nov; 28(6):408-414. PubMed ID: 34326286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regression of steatohepatitis-related cirrhosis.
    Deniz K; Özcan S; Özbakır Ö; Patıroğlu TE
    Semin Liver Dis; 2015 May; 35(2):199-202. PubMed ID: 25974904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liver extracellular matrix in health and disease.
    Bedossa P; Paradis V
    J Pathol; 2003 Jul; 200(4):504-15. PubMed ID: 12845618
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liver biopsy assessment in chronic hepatitis.
    Lefkowitch JH
    Arch Med Res; 2007 Aug; 38(6):634-43. PubMed ID: 17613355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systematic quantification of histological patterns shows accuracy in reflecting cirrhotic remodeling.
    Wang Y; Huang W; Li R; Yun Z; Zhu Y; Yang J; Liu H; Liu Z; Feng Q; Hou J
    J Gastroenterol Hepatol; 2017 Sep; 32(9):1631-1639. PubMed ID: 28068755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.